Five-Year Impact of the COVID-19 Pandemic on the Oncology Community
Leading multidisciplinary oncology professionals look back at how the COVID-19 pandemic changed cancer care.
3 Things You Should Know About Recognizing LEMS in Patients With SCLC
In patients with small cell lung cancer, Lambert-Eaton myasthenic syndrome leads to muscle weakness and can be discovered with no-cost testing such as anti-VGCC antibody testing.
3 Things You Should Know About Managing ALK+ Metastatic NSCLC
Multidisciplinary approaches, RNA-based next-generation sequencing, and patient-specific front-line treatment decisions are all important for curating effective NSCLC treatments.
3 Things You Should Know About Treating Epithelioid Sarcoma
Epithelioid sarcoma is individualized based on disease characteristics, it's methods of treatment vary, and systemic treatment is both targeted medication and chemotherapy.
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies
Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
Updates in Surgical Management of the Axilla
Axillary management of patients with breast cancer such as sentinel lymph node biopsy have evolved substantially over the past 30 years.
Five Years After the COVID-19 Pandemic: Effects on Cancer Care
Julie M. Vose, MD, MBA, discusses some of the lasting effects that the COVID-19 pandemic has had on the current state of cancer care.
Improvements Over Chemo Yield Sotorasib Combo Approval in KRAS G12C+ CRC
Adding panitumumab to sotorasib has yielded higher responses rates in KRAS G12C-mutated CRC compared with prior standards of care.
Integrating Psilocybin-Assisted Psychotherapy in Comprehensive Cancer Care
Micheal P. Bogenschutz, MD, discussed addressing unmet needs, implementation, and adverse effects related to psilocybin-assisted psychotherapy in cancer.